|
|
|
Volumn 12, Issue 4, 1999, Pages
|
|
New anti-HIV drug interactions, toxicities, and dosing options.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIDEPRESSANT AGENT;
GROWTH HORMONE;
LIPID;
METHADONE;
NEW DRUG;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ARTICLE;
BLOOD;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG COMBINATION;
DRUG INTERACTION;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIPODYSTROPHY;
LIVER DISEASE;
MALE;
METABOLISM;
ANTI-HIV AGENTS;
ANTIDEPRESSIVE AGENTS;
CLINICAL TRIALS;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
DRUGS, INVESTIGATIONAL;
FEMALE;
GROWTH HORMONE;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
LIPIDS;
LIPODYSTROPHY;
LIVER DISEASES;
MALE;
METHADONE;
REVERSE TRANSCRIPTASE INHIBITORS;
|
|
EID: 0033289521
PISSN: 1058708X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
